Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 7.14% is 240% above its 5-year average of -5.09%, near the high end of its 5-year range (-14.53%–7.14%).
310.31% above its 12-month average of -3.40%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 4.11%.
RETURN ON ASSETS (ROA)
7.14%
RETURN ON ASSETS (ROA) AVG TTM
-3.40%
RETURN ON ASSETS (ROA) AVG 3Y
-2.46%
RETURN ON ASSETS (ROA) AVG 5Y
-5.09%
RETURN ON ASSETS (ROA) AVG 10Y
-4.17%
RETURN ON ASSETS (ROA) AVG 15Y
1.96%
RETURN ON ASSETS (ROA) AVG 20Y
-0.03%
CURRENT VS TTM AVG
+310.31%
CURRENT VS 3Y AVG
+390.54%
CURRENT VS 5Y AVG
+240.32%
CURRENT VS 10Y AVG
+271.04%
CURRENT VS 15Y AVG
+263.91%
CURRENT VS 20Y AVG
+21736.36%
SECTOR MEDIAN · HEALTHCARE
-29.11%
median of 604 covered companies
CURRENT VS SECTOR MEDIAN
+124.53%
vs the sector median at left
LivaNova PLC
Market Cap
$4.14B
Return on Assets (ROA)
7.14%
TTM Avg
-3.40%
3Y Avg
-2.46%
5Y Avg
-5.09%
Market Cap
$4.03B
Return on Assets (ROA)
-12.59%
TTM Avg
-11.38%
3Y Avg
-5.58%
5Y Avg
0.19%
Market Cap
$4.24B
Return on Assets (ROA)
-41.11%
TTM Avg
-28.92%
3Y Avg
-26.43%
5Y Avg
-22.29%
Market Cap
$3.96B
Return on Assets (ROA)
0.76%
TTM Avg
-1.39%
3Y Avg
-1.28%
5Y Avg
0.88%
Market Cap
$4.38B
Return on Assets (ROA)
28.79%
TTM Avg
8.79%
3Y Avg
1.95%
5Y Avg
1.56%
Market Cap
$4.35B
Return on Assets (ROA)
-34.36%
TTM Avg
-56.86%
3Y Avg
-55.14%
5Y Avg
-55.14%
Market Cap
$4.45B
Return on Assets (ROA)
-9.97%
TTM Avg
-20.59%
3Y Avg
-24.65%
5Y Avg
-22.36%
Market Cap
$4.61B
Return on Assets (ROA)
-31.79%
TTM Avg
-38.86%
3Y Avg
-47.00%
5Y Avg
-47.76%
Market Cap
$4.64B
Return on Assets (ROA)
2.32%
TTM Avg
-1.14%
3Y Avg
-5.25%
5Y Avg
-6.57%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LivaNova PLC (LIVN) | $4.14B | 7.14% | -3.40% | -2.46% | -5.09% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.03B | -12.59% | -11.38% | -5.58% | 0.19% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.24B | -41.11% | -28.92% | -26.43% | -22.29% |
| ICU Medical, Inc. (ICUI)vs › | $3.96B | 0.76% | -1.39% | -1.28% | 0.88% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.38B | 28.79% | 8.79% | 1.95% | 1.56% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.35B | -34.36% | -56.86% | -55.14% | -55.14% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | -9.97% | -20.59% | -24.65% | -22.36% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.61B | -31.79% | -38.86% | -47.00% | -47.76% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.64B | 2.32% | -1.14% | -5.25% | -6.57% |
| BillionToOne, Inc. (BLLN)vs › | $4.69B | 4.59% | -6.29% | -18.57% | -18.57% |
ROA
7.1%
ROE
14.2%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -9.31% |
| 2024-12-31 | 2.52% |
| 2023-12-31 | 0.72% |
| 2022-12-31 | -3.76% |
| 2021-12-31 | -6.17% |
| 2020-12-31 | -14.53% |
| 2019-12-31 | -6.54% |
| 2018-12-31 | -7.43% |
| 2017-12-31 | -1.00% |
| 2016-12-31 | -2.68% |
| 2015-12-31 | 2.26% |
| 2015-04-30 | 18.66% |
| 2013-04-30 | 17.56% |
| 2012-04-30 | 17.03% |
| 2011-04-30 | 22.10% |
| 2010-04-30 | 37.81% |
| 2009-04-30 | 18.28% |
| 2008-04-30 | -9.83% |
| 2007-04-30 | -37.57% |
| 2006-04-30 | -38.78% |
| 2005-04-30 | -12.36% |
| 2004-04-30 | 7.17% |
| 2003-04-30 | 5.45% |
| 2002-04-30 | -37.37% |
| 2001-04-30 | 0.00% |
| 2000-06-30 | -7.63% |
| 1999-06-30 | -31.41% |
| 1998-06-30 | -33.73% |
| 1997-06-30 | -21.29% |
| 1996-06-30 | -258.97% |
